3 employees
SILKTECH focuses on innovating and developing silk-derived protein (SDP) products for ophthalmic applications
2013
$11M
from 2 investors over 2 rounds
SilkTech Biopharmaceuticals raised $6.2M on April 16, 2019
Investors: Skyview Capital LLC
SilkTech Biopharmaceuticals raised $11M on October 1, 2017